A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib

Overview of attention for article published in Breast Cancer Research and Treatment, December 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 1 X user

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 56 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 1 X post from an account with 731 followers.

@ICORG_Ireland do amazing work moving science results like ours to where it can help patients http://t.co/yEfBdHtGPR https://t.co/gjxrgTl8OL

Reply Repost Favourite